Litigation Details for Noven Pharmaceuticals, Inc. v. Mylan Technologies Inc. (D. Del. 2017)
✉ Email this page to a colleague
Noven Pharmaceuticals, Inc. v. Mylan Technologies Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-12-08 |
| Court | District Court, D. Delaware | Date Terminated | 2018-08-31 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Patents | 9,724,310; 9,730,900; 9,833,419 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Noven Pharmaceuticals, Inc. v. Mylan Technologies Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Noven Pharmaceuticals, Inc. v. Mylan Technologies Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-12-07 | 1 | infringement of U.S. Patent Nos. 9,730,900 (“the ’900 patent”) and 9,724,310 (“the ’310 patent”) (collectively…of the ’900 patent. COUNT III – INFRINGEMENT OF U.S. PATENT NO. 9,724,310 154.… INFRINGEMENT OF U.S. PATENT NO. 9,724,310 168. Noven repeats and realleges…collectively, “patents-in-suit”) arising under the United States Patent Laws, Title 35, United States Code § …includes acts of patent infringement in the State of Delaware, including acts of patent infringement with | External link to document | |
| 2018-02-28 | 26 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,833,419 B2; . (Kraftschik, …2017 31 August 2018 1:17-cv-01777 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| 2017-12-07 | 4 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,730,900 B2; 9,724,310 B2. (fms) (Entered…2017 31 August 2018 1:17-cv-01777 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
